Clinical Trial: Multimodal Biomarkers in Individual With Cognitive Impairment and Dementia

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812480) titled 'Multimodal Biomarkers in Individual With Cognitive Impairment and Dementia' on Sept. 01.

Brief Summary: Memory problems can range from normal aging to mild cognitive impairment (MCI) to dementia. This study looks at three ways of measuring what is happening in the brain at each of these stages: a blood test (GFAP), a brain MRI scan, and a brain wave test (EEG). The goal is to see whether combining these three tests can help doctors tell the difference between normal aging, MCI, and dementia more accurately, and whether this approach works well in an Egyptian population, including all common causes of dementia (not only Alzheimer's ...